Dialysis congestive heart failure

Dialysis congestive heart failure

Doctor discusses relationship between heart and kidneys

Kidney disease can be caused by heart disease, but heart disease can also be caused by kidney disease. Heart disease is the leading cause of death for dialysis patients. When your kidneys aren’t running well, they can’t sustain the rest of your body as well as they should. This can put your heart in jeopardy.
Heart disease also has no signs until the heart and blood vessels have been severely compromised. Preventing conditions that can lead to heart failure, such as anemia, high blood pressure, and calcium and phosphate imbalances, is the safest way to stop heart disease.
Making healthy lifestyle decisions can help to prevent or treat many forms of heart disease. These include eating a low-salt, low-fat diet, exercising, handling tension, and, if you smoke, stopping.
Heart disease is the leading cause of death for dialysis patients. Working with your doctor to make some lifestyle improvements that can reduce your risk of heart disease or make it worse is important. When you have kidney disease, you should take the following precautions to prevent heart disease:

Is there a connection between heart disease and kidney

In the dialysis community, congestive heart failure (CHF) is linked to a high mortality rate as well as a significant financial and healthcare burden. Determining through dialysis modality is linked to a higher risk of CHF in the dialysis population could help with clinical decision-making and surveillance programs.
We collected all incident dialysis patients from January 1, 1998 to December 31, 2010 using the Taiwan National Health Insurance Database. The matched hemodialysis (HD) and peritoneal dialysis (PD) cohorts were developed using the propensity score matching process. For the HD and PD patients, the incidence rates and total incidence rates of CHF-related hospitalization were compared first. To account for possible confounders, multivariable subdistribution hazards models were developed.
A total of 4,754 matched pairs of HD and PD patients were found among 65,899 dialysis patients. CHF was observed in 25.98 and 19.71 per 1000 patient-years in matched HD and PD patients, respectively (P = 0.001). The combined incidence rate of CHF was also higher in matched HD patients (0.16, 95 percent confidence interval (CI)(0.12–0.21)] than in PD patients (0.09, 95 percent confidence interval (CI)[0.08–0.11])(P0.0001). In the matched cohort, HD was consistently correlated with a higher subdistribution hazard ratio (HR) of CHF than PD (HR: 1.45, 95 percent CI [1.23–1.7]). Similar results were observed in both the subgroup study stratified by selected confounders and the HD and PD group without matching.

Mangement of heart failure in ckd

Renal dysfunction is associated with a poor prognosis in patients with congestive heart failure (CHF); even mild changes in plasma creatinine are related to an increased risk of death. Prognostic indices and outcomes in patients with CHF who (sub-)acutely progress to dialysis dependence are, however, poorly understood.
A total of 46 patients with CHF (NYHA III-IV) and dialysis-dependent renal failure (acute and acute-to-chronic renal failure) with dialysis-dependent renal failure (acute and acute-to-chronic renal failure) were studied. Patient characteristics, demographic variables, cardiac function parameters, and renal parameters were all tracked over time.
Patients with CHF who progressed to dialysis-dependent renal failure had a poor prognosis, with a median survival period of 95 days and a mean survival time of 444 days. Except for age, none of the identified variables were related to a poorer outcome in CHF patients. LV/RV dysfunction, elevated plasma NT-pro-BNP, C-reactive protein, low albumin, and a low BMI were not found to be prognostic indicators. Renal function regeneration and low hemoglobin were the only factors that predicted enhanced survival.

Cardiorenal syndrome – classification, mechanism

The official publication of the Spanish Society of Nephrology is Nefrologa. The Journal publishes papers on nephrology, arterial hypertension, dialysis, and kidney transplants that are focused on basic or clinical studies. All original papers are subject to internal and external reviews and are regulated by the peer review system. Reports in both English and Spanish are authorized for publication in the journal. Nefrologa adheres to the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics’ publication guidelines (COPE).